Provider Disclaimer Clinical Judgment and Individualized Care This protocol is intended as a general guideline for qualified healthcare providers
The FDA has approved weight loss drugs in the medication class known as GLP-1 receptor agonists, which have been proven safe and effective for treating conditions such as type II diabetes, regulating blood glucose levels, losing weight, and decreasing the risk of cardiovascular diseases
HRH2 gene: Histamine receptor 2 is active in the production of stomach acid, the sinus node of the heart, and other places in the body
NICE and NHS guidance recommends that individuals in high-risk groups are monitored and treated appropriately
Across the GLP-1 telehealth market as of April 2026, monthly totals commonly fall between roughly $200 and $700 or more depending on medication, tier, and dispensing route